The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Rowland Lloyd A since 2006.
This trader's CIK number is 1236395.
At the time of last reporting, Rowland Lloyd A was the General Counsel of Cytomx Therapeutics, Inc.. (stock ticker symbol CTMX).
Also see all insider trading activities at Cytomx Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | CTMX | 0 | $0 | 10,203 | $6,111 | 0 | $0 |
| 2024 | CTMX | 0 | $0 | 4,181 | $5,138 | 11,250 | $0 |
| 2023 | CTMX | 0 | $0 | 11,600 | $16,798 | 0 | $0 |
| 2022 | CTMX | 0 | $0 | 5,602 | $7,966 | 0 | $0 |
| 2019 | CTMX | 9,000 | $92,970 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | AMLN | 0 | $0 | 8,000 | $189,149 | 5,000 | $45,100 |
| 2008 | AMLN | 0 | $0 | 100 | $3,500 | 100 | $1,654 |
| 2007 | AMLN | 0 | $0 | 27,000 | $1,134,862 | 30,000 | $429,440 |
| 2006 | AMLN | 0 | $0 | 29,500 | $1,278,424 | 35,500 | $211,865 |
1. Cytomx Therapeutics, Inc. (CTMX)
2. Amylin Pharmaceuticals Inc (AMLN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-18 | CTMX | Sale | 10,203 | .60 | 6,111 |
| 2024-08-20 | CTMX | Option Ex | 11,250 | .00 | 0 |
| 2024-08-20 | CTMX | Sale | 4,181 | 1.23 | 5,138 |
| 2023-12-20 | CTMX | Sale | 4,077 | 1.38 | 5,630 |
| 2023-09-22 | CTMX | Sale | 5,486 | 1.30 | 7,137 |
| 2023-03-16 | CTMX | Sale | 2,037 | 1.98 | 4,031 |
| 2022-07-20 | CTMX | Sale | 5,602 | 1.42 | 7,966 |
| 2019-03-04 | CTMX | Buy | 9,000 | 10.33 | 92,970 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-03-29 | AMLN | Sale | 3,000 | 25.00 | 75,000 |
| 2012-03-28 | AMLN | Sale | 5,000 | 22.83 | 114,149 |
| 2012-03-28 | AMLN | Option Ex | 5,000 | 9.02 | 45,100 |
| 2008-08-18 | AMLN | Sale | 100 | 35.00 | 3,500 |
| 2008-08-18 | AMLN | Option Ex | 100 | 16.54 | 1,654 |
| 2007-12-03 | AMLN | Sale | 2,000 | 37.55 | 75,110 |
| 2007-12-03 | AMLN | Option Ex | 2,000 | 16.54 | 33,080 |
| 2007-11-01 | AMLN | Sale | 2,000 | 44.16 | 88,310 |
| 2007-11-01 | AMLN | Option Ex | 2,000 | 16.54 | 33,080 |
| 2007-10-01 | AMLN | Option Ex | 2,000 | 16.54 | 33,080 |
| 2007-10-01 | AMLN | Sale | 2,000 | 49.67 | 99,340 |
| 2007-09-04 | AMLN | Option Ex | 2,000 | 20.73 | 41,450 |
| 2007-09-04 | AMLN | Sale | 2,000 | 48.99 | 97,988 |
| 2007-08-01 | AMLN | Option Ex | 2,000 | 18.85 | 37,700 |
| 2007-08-01 | AMLN | Sale | 2,000 | 46.31 | 92,622 |
| 2007-07-02 | AMLN | Option Ex | 2,000 | 18.85 | 37,700 |
| 2007-07-02 | AMLN | Sale | 2,000 | 41.00 | 82,000 |
| 2007-06-01 | AMLN | Sale | 2,000 | 46.64 | 93,280 |
| 2007-06-01 | AMLN | Option Ex | 2,000 | 18.85 | 37,700 |
| 2007-05-01 | AMLN | Option Ex | 5,000 | 11.95 | 59,750 |
| 2007-05-01 | AMLN | Sale | 5,000 | 41.50 | 207,500 |
| 2007-04-02 | AMLN | Sale | 2,000 | 36.95 | 73,900 |
| 2007-04-02 | AMLN | Option Ex | 2,000 | 11.95 | 23,900 |
| 2007-03-01 | AMLN | Option Ex | 2,000 | 11.95 | 23,900 |
| 2007-03-01 | AMLN | Sale | 2,000 | 37.39 | 74,772 |
| 2007-02-01 | AMLN | Option Ex | 2,000 | 11.95 | 23,900 |
| 2007-02-01 | AMLN | Sale | 2,000 | 38.92 | 77,840 |
| 2007-01-03 | AMLN | Option Ex | 5,000 | 8.84 | 44,200 |
| 2007-01-03 | AMLN | Sale | 2,000 | 36.10 | 72,200 |
| 2006-12-01 | AMLN | Sale | 2,000 | 39.39 | 78,780 |
| 2006-12-01 | AMLN | Option Ex | 2,000 | 11.95 | 23,900 |
| 2006-11-01 | AMLN | Sale | 2,000 | 44.01 | 88,020 |
| 2006-11-01 | AMLN | Option Ex | 2,000 | 5.73 | 11,460 |
| 2006-10-02 | AMLN | Option Ex | 2,000 | 5.73 | 11,460 |
| 2006-10-02 | AMLN | Sale | 2,000 | 43.07 | 86,146 |
| 2006-09-01 | AMLN | Option Ex | 2,000 | 5.66 | 11,320 |
| 2006-09-01 | AMLN | Sale | 2,000 | 45.21 | 90,420 |
| 2006-08-01 | AMLN | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-08-01 | AMLN | Sale | 2,000 | 47.43 | 94,862 |
| 2006-07-03 | AMLN | Sale | 2,000 | 48.02 | 96,040 |
| 2006-07-03 | AMLN | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-06-29 | AMLN | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-06-12 | AMLN | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-06-01 | AMLN | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-06-01 | AMLN | Sale | 2,000 | 45.57 | 91,140 |
| 2006-05-01 | AMLN | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-05-01 | AMLN | Sale | 2,000 | 43.00 | 86,000 |
| 2006-04-03 | AMLN | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-04-03 | AMLN | Sale | 2,000 | 46.88 | 93,770 |
| 2006-03-01 | AMLN | Sale | 3,000 | 43.00 | 129,000 |
| 2006-03-01 | AMLN | Option Ex | 3,000 | 5.59 | 16,770 |
| 2006-02-01 | AMLN | Option Ex | 3,000 | 5.59 | 16,770 |
| 2006-02-01 | AMLN | Sale | 3,000 | 41.71 | 125,121 |
| 2006-01-17 | AMLN | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-01-03 | AMLN | Option Ex | 2,000 | 5.59 | 11,180 |
| 2005-12-30 | AMLN | Option Ex | 3,500 | 5.59 | 19,565 |
| 2006-01-03 | AMLN | Sale | 2,000 | 40.00 | 80,000 |
| 2005-12-30 | AMLN | Sale | 3,500 | 39.75 | 139,125 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rowland Lloyd A (General Counsel of Cytomx Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.